# Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring

> **NCT02920827** · PHASE1 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 16 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **COMBINATION_PRODUCT:** Dapivirine Vaginal Ring
- **COMBINATION_PRODUCT:** Placebo vaginal ring

## Key facts

- **NCT ID:** NCT02920827
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02920827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02920827, "Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02920827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
